Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00588939 · ClinicalTrials.gov registry record
Confocal Laser Microscopy in Non Erosive Reflux Disease
A clinical trial of Heartburn and Acid Reflux Disease, sponsored by Mayo Clinic.
- Completed
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT00588939 is a study of Heartburn and Acid Reflux Disease that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 413-participant average among 9 other Heartburn trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00588939, a study of Heartburn and Acid Reflux Disease, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Heartburn or reflux disease affects about 20% of Americans. 50 - 70% of people who have endoscopy for reflux disease have a normal appearing esophagus. Confocal Laser Microscopy allows us to see changes in the cells not visable during routine endoscopy. Whe goal of this study is to identify the use of this new technique in diagnosing reflux in patients who have normal appearing esophagus.
Conditions Studied
Interventions
- DEVICE Cell~vizio (Laser connfocal microscopy)
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-11 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00588939
The ClinicalTrials.gov registry entry for NCT00588939 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 413-participant average among 9 other Heartburn trials with a reported enrollment target (85% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heartburn appearing as the primary indexed condition, and to 1 intervention - of which Cell~vizio (Laser connfocal microscopy) is the first listed.
NCT00588939 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT00588939 about?
NCT00588939 is a clinical study titled "Confocal Laser Microscopy in Non Erosive Reflux Disease". Heartburn or reflux disease affects about 20% of Americans. 50 - 70% of people who have endoscopy for reflux disease have a normal appearing esophagus. Confocal Laser Microscopy allows us to see changes in the cells not visable during routine endoscopy. Whe goal of this study is to identify the use ...
What is the current status of trial NCT00588939?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2008-11. Estimated completion is 2012-12.
What conditions does trial NCT00588939 study?
This clinical trial studies the following conditions: Heartburn, Acid Reflux Disease.
What interventions are being tested in trial NCT00588939?
The interventions under investigation include: Cell~vizio (Laser connfocal microscopy) (DEVICE).
Who is sponsoring clinical trial NCT00588939?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00588939 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heartburn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Breath Testing for Small Intestinal Bacterial Overgrowth
RECRUITING · NA
-
Domperidone in Treating Patients With Gastrointestinal Disorders
RECRUITING · Phase 3
-
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
RECRUITING
-
Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn
COMPLETED · Phase 3
-
E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
COMPLETED · Phase 3
-
E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.